| Parenterals Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 491
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen, Giuliano Karen, Middleton Aurea
|
Mar/Apr 2023
Pg. 169-174
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
|
May/Jun 2022
Pg. 248-254
|
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 129-136
|
Calculations
Stockton Shelly J
|
Mar/Apr 2022
Pg. 138
|
Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
|
Jan/Feb 2022
Pg. 10-17
|
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
|
Nov/Dec 2021
Pg. 446-462
|
Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel, Soumoy Laura
|
Nov/Dec 2021
Pg. 510-514
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 403-408
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
Calculations
Stockton Shelly J
|
May/Jun 2021
Pg. 230-231
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 42
|
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
|
Jan/Feb 2021
Pg. 73-81
|
Establishing a Structured Pharmacy Training Program in Sterile Compounding
Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
|
Nov/Dec 2020
Pg. 460-465
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 388-395
|
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions
Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
|
Sep/Oct 2020
Pg. 420-425
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
|
May/Jun 2020
Pg. 215-220
|
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 121-126
|
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia
Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
|
Mar/Apr 2020
Pg. 156-162
|
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
|
Nov/Dec 2019
Pg. 447-452
|
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 478-482
|
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Stability of Furosemide 5 mg/mL in Polypropylene Syringes
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
|
Sep/Oct 2019
Pg. 414-417
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 444
|
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
|
Jul/Aug 2018
Pg. 335-339
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M, Brown Michael C, Zavala Pedro J
|
Jan/Feb 2018
Pg. 41-46
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Trace Elements Injection 5
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 498
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017
Pg. 518-529
|
Calculations
Stockton Shelly J
|
Sep/Oct 2017
Pg. 406
|
Ioversol Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 413
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 66-75
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
|
Jul/Aug 2016
Pg. 328-332
|
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
|
Jul/Aug 2016
Pg. 343-346
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 226
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 234
|
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
|
May/Jun 2016
Pg. 236-238
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Calculations
Stockton Shelly J
|
Mar/Apr 2016
Pg. 142
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Basic Principles of Lyophilization, Part 2
Akers Michael J
|
Jan/Feb 2016
Pg. 20-27
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Calculations
Stockton Shelly J
|
Nov/Dec 2015
Pg. 502
|
Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 324
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 144
|
Morrhuate Sodium 5% Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 147
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Zinc 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 331
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Calculations
Stockton Shelly J
|
Mar/Apr 2014
Pg. 140-141
|
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
|
Mar/Apr 2014
Pg. 152-158
|
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013
Pg. 270-280
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 330
|
Ketamine 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 331
|
Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 332
|
Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 333
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013
Pg. 100-110
|
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013
Pg. 168-174
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Nicardipine Hydrochloride Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 71
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Nov/Dec 2012
Pg. 498-499
|
Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 500
|
Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 501
|
Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 502
|
Copper 0.4-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 503
|
Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 504
|
Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 505
|
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 506
|
Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 507
|
Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 508
|
Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 509
|
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Zhang Yang, Scarlett Cameron, Hutson Paul
|
Jan/Feb 2012
Pg. 82-85
|
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients
Nolan Sara M, Burgess Christopher A
|
Nov/Dec 2011
Pg. 446-448
|
Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
|
Jul/Aug 2011
Pg. 270-276
|
Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D, Peacock Gina F, Smith Douglas L
|
May/Jun 2011
Pg. 252-254
|
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R, Saraf Poonam
|
May/Jun 2011
Pg. 259-261
|
Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve, Williams LaVonn A
|
May/Jun 2011
Pg. 183-188
|
Drug Compatibility and Stability in Dextrose vs Saline
Newton David W
|
May/Jun 2011
Pg. 190-192
|
Home Infusion Basics for the Non-Infusion Pharmacist
Miron Karen E
|
Mar/Apr 2011
Pg. 94-100
|
Home Infusion 101
Williams LaVonn A
|
Jan/Feb 2011
Pg. 6-10
|
Maillard Reactions in Pharmaceutical Formulations and Human Health
Newton David W
|
Jan/Feb 2011
Pg. 32-40
|
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
|
Jan/Feb 2011
Pg. 49-54
|
Home Infusion: Overcoming the Barriers to Entry
Franklin David M
|
Nov/Dec 2010
Pg. 450-455
|
Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
|
Sep/Oct 2010
Pg. 360-364
|
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Baker Daniel S, Waldrop Bruce, Arnold John
|
Jul/Aug 2010
Pg. 346-349
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2010
Pg. 142-149
|
Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 156
|
Metolazone 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 157
|
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector
Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
|
Mar/Apr 2010
Pg. 160-164
|
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam
Veggeland Turid, Brandl Martin
|
Jan/Feb 2010
Pg. 78-81
|
Ionic Hydration Solution for Anti-Cancer Therapy
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 156
|
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
|
Jan/Feb 2009
Pg. 78-80
|
Equine Anesthesia: Triple Drip
Davidson Gigi S
|
Sep/Oct 2008
Pg. 402-404
|
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008
Pg. 460-462
|
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Sep/Oct 2008
Pg. 463-466
|
Glycerin, Sterile
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 542
|
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Nov/Dec 2008
Pg. 553-557
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
|
May/Jun 2008
Pg. 274-275
|
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008
Pg. 276-278
|
Chemical Stability of Tramadol Hydrochloride Injection
Gupta Vishnu D
|
Mar/Apr 2008
Pg. 161-162
|
Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 68
|
Flosulide 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 69
|
Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008
Pg. 83-85
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Calculations: High-Technology Compounding and Investigational Dispensing
Webb Sheldon D, Stockton Shelly J
|
Nov/Dec 2007
Pg. 500-501
|
Lidocaine Hydrochloride 1.82% Buffered Injection
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 511
|
The Whales: A Pharmacist's Story
Wills William R
|
Sep/Oct 2007
Pg. 376-383
|
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007
Pg. 426-432
|
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 328
|
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 335
|
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Jan/Feb 2007
Pg. 82-85
|
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Gupta Vishnu D
|
Jul/Aug 2006
Pg. 318-319
|
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>
Driscoll David F, Nehne Jorg, Horst Peterss, Klutsch Karsten, Bistrian Bruce R, Wilhelm Niemann
|
Jul/Aug 2006
Pg. 309-315
|
Using ACDs in the Practice of Pharmacy
Kastango Eric S
|
Jan/Feb 2005
Pg. 15-21
|
PostScription: Cleanroom Standards
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004
Pg. 160
|
Glycerin 50% Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 54
|
Vancomycin HCl and Heparin Sodium Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 60
|
Total Parenteral Nutrition for Animals
Sammarco Domenic A
|
Sep/Oct 2002
Pg. 328-330
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Basics of Compounding: Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 441-447
|
Total Parenteral Nutrition Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 458
|
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
|
Sep/Oct 1999
Pg. 415-420
|
Parenteral Nutrition Equipment and Devices
Bertch Karen E
|
Sep/Oct 1998
Pg. 338-341
|
Catheter Occlusion: Causes and Solutions
McKinnon Barbara, Lima Hetty A
|
Sep/Oct 1998
Pg. 342-346
|
TPN Bulk Compounding from Bulk Drug Substances
Chamallas Stanley N
|
Sep/Oct 1998
Pg. 347-349
|
The Feasibility and Benefits of TPN in Horses: A Review of the Findings
Paoletti James E, Downing Dee, Tormo Vicente J
|
Sep/Oct 1998
Pg. 351-353
|
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 366
|
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 367
|
Pediatric Central Parenteral Nutrition Solution
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 368
|
Pediatric Central Parenteral Nutrition Solution with Heparin
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 369
|
Pediatric Peripheral Parenteral Nutrition Solution
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 370
|
Three-in-One Adult Total Parenteral Nutrition
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 371
|
Testing for Bacterial Endotoxins
Jelinek Todd
|
Sep/Oct 1998
Pg. 379
|
Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 380-381
|
Parenteral Admixture Incompatibilities:An Introduction
Allen Loyd V Jr
|
May/Jun 1997
Pg. 165-167
|
| Return to Top |
